New study to measure hidden toll of painful skin condition

NCT ID NCT07323303

Not yet recruiting Knowledge-focused Sponsor: PeriPharm Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 100 Canadian adults with hidradenitis suppurativa (HS), a painful skin condition, to measure how it affects their work and daily life. Participants will fill out questionnaires about work productivity and quality of life. No treatment is given—the goal is to better understand the burden of HS and identify unmet needs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could highlight gaps in care and guide better support for people living with hidradenitis suppurativa in Canada.
What could go wrong
This is an observational study with no treatment being tested, so it will not directly improve symptoms. Results depend on patient self-reports and may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.